Site icon YourLifeChoices

TGA recalls cough syrups and lozenges over anaphylaxis risk

cough lozenges

The Therapeutic Goods Administration (TGA) has recalled 44 products containing the cough suppressant pholcodine after an investigation linked the ingredient with an increased risk of potentially fatal anaphylactic reactions to other medicines used during general anaesthesia.

The pholcodine-containing products have also been cancelled from the Australian Register of Therapeutic Goods — along with another 11 products not currently on shelves — meaning they will no longer be able to be lawfully supplied in Australia.

The recall affects a range of cough syrups and lozenges manufactured by Benadryl, Codral, Chemists’ Own, TerryWhite, Priceline, Difflam, Bisolvon, Duro-Tuss and others.

Pholcodine – an opioid that works directly in the brain to suppress the cough reflex by reducing nerve signals – has been in use since the 1950s, and is contained in a variety of over-the-counter medicines.

In addition to cough syrups and lozenges aimed at treating dry coughs, it can be found in products that treat cold and flu symptoms more broadly.

Anaesthetists have been calling on the TGA to recall the products for years, citing evidence that showed differing rates of anaphylaxis in Norway, which had high pholcodine use before withdrawing it from the market in 2007, and Sweden, where it was not marketed since the late 1980s.

In issuing the recall, the TGA said it now suspected 50 cases in Australia of reported adverse reactions to neuromuscular blockers – medicines used as muscle relaxants during general anaesthesia – were in fact pholcodine-related anaphylactic reactions, including one case in which the patient died.

TGA head Dr John Skerritt is urging people to check if any of their cold and flu medicines contain pholcodine. (ABC News)

The head of the TGA, Dr John Skerritt, said the broad recall was being undertaken because it was difficult to accurately ascertain who has taken medicines containing pholcodine in the 12 months before undergoing surgery.

“While surgical facilities may ask about which prescription medicines a patient is taking, they may not ask about over-the-counter products,” Dr Skerritt said.

“Some patients undergoing emergency surgery may not be in a position to talk to their anaesthetist at all.”

He said health professionals who currently have patients scheduled to undergo general anaesthesia should check whether patients have used pholcodine in the past 12 months.

What do consumers need to do?

Anyone in possession of over-the-counter cold and flu medication, in particular lozenges or syrups, should check the ingredients to see if they contain pholcodine.

If they do, people should ask their doctor or pharmacist to suggest an alternative.

If someone suspects they have taken pholcodine over the past 12 months and is due to undergo general anaesthesia, they should tell their health professional prior to the procedure.

A full list of the recalled products can be found at the bottom of this article.

‘It’s amazing that it lasted so long’

Professor Ian Rae, an expert on chemicals in the environment at the University of Melbourne’s School of Chemistry, says the TGA “acted appropriately” in taking pholcodine products off the market.

“It’s surprising that [concerns] about its side-effects have taken so long to emerge,” Prof. Rae said.

“It’s amazing that it lasted so long, but then, it’s only in recent years that use of another widely used opiate, codeine, has been restricted.

“Another opiate bites the dust.”

The head of Flinders University’s Clinical Epidemiology Research Group, Dr Ashley Hopkins, agreed that the decision to deregister pholcodine was a welcome one, saying it was based on strong scientific evidence.

“These reactions can occur even in patients who have no history of allergy to any other medication,” Dr Hopkins said.

“As healthcare professionals, our primary concern is the safety and wellbeing of our patients and removing a medication that poses such a significant risk is a necessary step in ensuring that patient safety is maintained.”

What products are covered by the recall?

Here is the full list of recalled products, as supplied to the ABC by the Therapeutic Goods Administration:

Do you use any of these cough syrups or lozenges? Do you know of any adverse reactions? Let us know in the comments section below.

© 2020 Australian Broadcasting Corporation. All rights reserved.
ABC Content Disclaimer

Exit mobile version